Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 3.900
-0.100 (-2.50%)
At close: Nov 10, 2026
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 2.41 billion as of November 10, 2026. It is the 17,842nd most valuable company in the world and the 788th biggest in Hong Kong. Its market cap has decreased by 22.47% in one year.
Market Cap
2.41B
Enterprise Value
2.97B
Revenue
568.00K
Global Rank
Country Rank
#788 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 2.41B, a decrease of -80.12%. That is a compound annual growth rate of -29.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 2.41B | -2.50% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.24B |
| Beijing Luzhu Biotechnology | 3.06B |
| Frontage Holdings | 3.03B |
| Shanghai Bao Pharmaceuticals | 2.93B |
| Viva Biotech Holdings | 2.74B |
| Medtide | 2.74B |
| Laekna | 2.74B |
| BioDlink International Company | 2.63B |